TGY2IT
EW icon

Timothy G. Youngquist 2020 Irrevocable Trust’s Edwards Lifesciences EW Stock Holding History

Timothy G. Youngquist 2020 Irrevocable Trust’s Portfolio EW Stock Details EW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-204
Closed -$16.3K – 250
2026
Q1 		$16.3K Buy
+204
New +$16.8K 0.01% 333

Other funds holding EW

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
Ninety One (UK)
Ninety One (UK) London, United Kingdom $44.7B AUM 17.24% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $344B AUM 42.99% 1-Year Est. Return
WT
Wellcome Trust London, United Kingdom $9.01B AUM 12.05% 1-Year Est. Return
Russell Investments Group
Russell Investments Group London, United Kingdom $114B AUM 41.71% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return
Nordea Investment Management
Nordea Investment Management Stockholm, Sweden $123B AUM 38.85% 1-Year Est. Return
Universal-Beteiligungs- und Servicegesellschaft
Universal-Beteiligungs- und Servicegesellschaft Frankfurt Am Main, Germany $65.4B AUM 39.83% 1-Year Est. Return

Timothy G. Youngquist 2020 Irrevocable Trust's EW Position: Q2 2026 in Review

Timothy G. Youngquist 2020 Irrevocable Trust sold out of Edwards Lifesciences (EW) in Q2 2026, closing a stake of 204 shares — an estimated $16.3K sold.

Timothy G. Youngquist 2020 Irrevocable Trust first reported a position in EW in Q1 2026 and held it in 1 quarter. The position peaked at $16.3K in Q1 2026. 774 funds tracked by Wall St. Rank hold EW as of Q2 2026.

  • Timothy G. Youngquist 2020 Irrevocable Trust reported no remaining Edwards Lifesciences position as of Q2 2026 after selling out during the quarter.
  • Timothy G. Youngquist 2020 Irrevocable Trust sold 204 Edwards Lifesciences shares in Q2 2026, an estimated $16.3K.
  • Timothy G. Youngquist 2020 Irrevocable Trust first reported a position in Edwards Lifesciences in Q1 2026 and held it in 1 quarter.
  • Timothy G. Youngquist 2020 Irrevocable Trust's Edwards Lifesciences position peaked at $16.3K in Q1 2026.
  • 774 funds tracked by Wall St. Rank held Edwards Lifesciences as of Q2 2026.

Based on Timothy G. Youngquist 2020 Irrevocable Trust's 13F filing for Q2 2026, filed 7 Aug 2026.